Product to watch - SemaCyte® Multiplexing Platform
Portfolio company Semarion's SemaCyte® Multiplexing Platform was listed as one of the "Products to Watch" in Genetic Engineering & Biotechnology News.
In the May edition of Genetic Engineering & Biotechnology News, portfolio company Semarion's SemaCyte® Multiplexing Platform was listed as one of the "Products to Watch".
The SemaCyte Multiplexing Platform builds on the existing SemaCyte Microcarrier platform to enable optical barcoding and pooling of adherent cells to augment drug discovery high-content imaging and other screening processes.
Learn more about Semarion here: https://rb.gy/ldkc7g